Teva launches SYNCareTM to support patients taking Synribo
FRAZER, Pa. — Teva Pharmaceutical on Wednesday announced the launch of SYNCareTM, a program designed to support patients taking Synribo (omacetaxine mepesuccinate) for at-home injection.
Through the program, patients will receive:
- Home delivery of prepared, prescribed doses;
- All supplies needed for home administration;
- Educational and injection training resources; and
- A 24/7 toll-free hotline number.
Synribo recently received approval from the Food and Drug Administration for at-home administration. Adults with chronic or accelerated phase chronic myeloid leukemia who are no longer responding to (or who were not able to tolerate,) two or more tyrosine kinase inhibitors now have the option of administering the drug at home.
"The comprehensive level of support provided through SYNCare will help my patients administer Synribo in their homes," said Meir Wetzler, M.D., FACP, chief of the leukemia section at Roswell Park Cancer Institute. "With supported home administration, patients living with CML are empowered with flexibility in their treatment regimen."
Teva has entered into an exclusive agreement with Diplomat Pharmacy to distribute Synribo to patients at home, the company said. Diplomat will ensure custom preparation by a healthcare professional of each dose and delivery of Synribo directly to the patient's home.
CVS Health’s Larry Merlo talks of name change, opportunities in health care on CNBC
WOONSOCKET, R.I. — Shortly after announcing Wednesday morning its corporate name change to CVS Health, CEO Larry Merlo appeared on CNBC to weigh in on the name change and the opportunities to play a greater role in today’s healthcare market, as well as to highlight the fact that its stores are now officially tobacco-free.
“We think about today’s announcement of our corporate name change to CVS Health as really catching up with some of the things that we’ve been doing for the last couple of years. We’ve got a big focus on keeping people adherent and compliant to their prescription medications,” Merlo said Wednesday on CNBC.
“We have many opportunities to play a bigger role in healthcare delivery. We have our 7,700 CVS pharmacies, we have our leading benefit management company and we have walk-in medical clinics now. So, we are doing many things to help change and shape the future of healthcare delivery,” Merlo added.
Meanwhile, the news that CVS Health has now officially ended tobacco sales at its pharmacy locations — nearly a month ahead of the previously targeted date of Oct. 1 — drew accolades from the White House.
“WH applauds CVS for ending sale of tobacco products. WH says it sets “a powerful example that we hope others in the industry will follow,” tweeted CBS News White House correspondent Mark Knoller.
Those who visit the company’s website also will notice the change. Reflecting a new look and feel and the new corporate name, the revamped CVS Health site states on the home page: “Our name has changed, but our purpose remains the same: helping people on their path to better health.”